Condition
Cervix
Total Trials
5
Recruiting
0
Active
0
Completed
3
Success Rate
75.0%-12% vs avg
Key Insights
Highlights
Success Rate
75% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
Termination Rate
20.0%
1 terminated out of 5 trials
Success Rate
75.0%
-11.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed with results
Key Signals
75% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 2 (1)
Trial Status
Completed3
Withdrawn1
Terminated1
Trial Success Rate
75.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT00250055Not ApplicableTerminatedPrimary
Non-Invasive, Real-Time Technology for Diagnosis of Cervical Tissue
NCT04413890Phase 2Completed
Comparison of Two Rhythm of Administration of Prostaglandin Gel for Induction of Labor
NCT00298064Not ApplicableWithdrawn
Assessment of EGFR Genomic Alterations as Prognostic Markers in Cervical Cancer
NCT03034434CompletedPrimary
Cervical Recuperation After Vaginal Delivery
NCT01605656Completed
A Mixed-Methods Approach to Understanding Factors Associated With Cervical Cancer Screening Utilization Among Low-Income, HIV-Positive Women
Showing all 5 trials